日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Erythrobacter litoralis Probable rRNA maturation factor (ELI_08505) CSB-YP640835EAAH
CSB-EP640835EAAH
CSB-BP640835EAAH
CSB-MP640835EAAH
CSB-EP640835EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Elongation factor G (fusA), partial CSB-YP640836EAAH
CSB-EP640836EAAH
CSB-BP640836EAAH
CSB-MP640836EAAH
CSB-EP640836EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis 30S ribosomal protein S3 (rpsC) CSB-YP640837EAAH
CSB-EP640837EAAH
CSB-BP640837EAAH
CSB-MP640837EAAH
CSB-EP640837EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis 50S ribosomal protein L6 (rplF) CSB-YP640838EAAH
CSB-EP640838EAAH
CSB-BP640838EAAH
CSB-MP640838EAAH
CSB-EP640838EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis 50S ribosomal protein L17 (rplQ) CSB-YP640839EAAH
CSB-EP640839EAAH
CSB-BP640839EAAH
CSB-MP640839EAAH
CSB-EP640839EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis ATP synthase subunit b (atpF), partial CSB-YP640840EAAH1
CSB-EP640840EAAH1
CSB-BP640840EAAH1
CSB-MP640840EAAH1
CSB-EP640840EAAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Gamma-glutamyl phosphate reductase (proA) CSB-YP640841EAAH
CSB-EP640841EAAH
CSB-BP640841EAAH
CSB-MP640841EAAH
CSB-EP640841EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP640842EAAH
CSB-EP640842EAAH
CSB-BP640842EAAH
CSB-MP640842EAAH
CSB-EP640842EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Ribosomal RNA small subunit methyltransferase I (rsmI) CSB-YP640843EAAH
CSB-EP640843EAAH
CSB-BP640843EAAH
CSB-MP640843EAAH
CSB-EP640843EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis 30S ribosomal protein S4 (rpsD) CSB-YP640844EAAH
CSB-EP640844EAAH
CSB-BP640844EAAH
CSB-MP640844EAAH
CSB-EP640844EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Protein translocase subunit SecA (secA), partial CSB-YP640845EAAH
CSB-EP640845EAAH
CSB-BP640845EAAH
CSB-MP640845EAAH
CSB-EP640845EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis 60 kDa chaperonin 1 (groL1), partial CSB-YP640846EAAH
CSB-EP640846EAAH
CSB-BP640846EAAH
CSB-MP640846EAAH
CSB-EP640846EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Uridylate kinase (pyrH) CSB-YP640847EAAH
CSB-EP640847EAAH
CSB-BP640847EAAH
CSB-MP640847EAAH
CSB-EP640847EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP640848EAAH
CSB-EP640848EAAH
CSB-BP640848EAAH
CSB-MP640848EAAH
CSB-EP640848EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP640849EAAH
CSB-EP640849EAAH
CSB-BP640849EAAH
CSB-MP640849EAAH
CSB-EP640849EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Recombination protein RecR (recR) CSB-YP640850EAAH
CSB-EP640850EAAH
CSB-BP640850EAAH
CSB-MP640850EAAH
CSB-EP640850EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP640851EAAH
CSB-EP640851EAAH
CSB-BP640851EAAH
CSB-MP640851EAAH
CSB-EP640851EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Protein CrcB homolog (crcB), partial CSB-YP640852EAAH1
CSB-EP640852EAAH1
CSB-BP640852EAAH1
CSB-MP640852EAAH1
CSB-EP640852EAAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erythrobacter litoralis Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP640853EAAH
CSB-EP640853EAAH
CSB-BP640853EAAH
CSB-MP640853EAAH
CSB-EP640853EAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosphaera stadtmanae 50S ribosomal protein L21e (rpl21e) CSB-YP640854MAAR
CSB-EP640854MAAR
CSB-BP640854MAAR
CSB-MP640854MAAR
CSB-EP640854MAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×